Analogues of the natural product gallinamide A were prepared to elucidate novel inhibitors of the falcipain cysteine proteases. Analogues exhibited potent inhibition of falcipain-2 (FP-2) and falcipain-3 (FP-3) and of the development of Plasmodium falciparum in vitro. Several compounds were equipotent to chloroquine as inhibitors of the 3D7 strain of P. falciparum and maintained potent activity against the chloroquine-resistant Dd2 parasite. These compounds serve as promising leads for the development of novel antimalarial agents
Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our curr...
Includes abstract.With the aim of designing appropriate hybrid molecules as a strategy to fight drug...
Falcipain-2 (FP-2) is a key cysteine protease from the malaria parasite Plasmodium falciparum. Many ...
Analogues of the natural product gallinamide A were prepared to elucidate novel inhibitors of the fa...
A library of analogues of the cyanobacterium-derived depsipeptide natural product gallinamide A were...
A library of analogues of the cyanobacterium-derived depsipeptide natural product gallinamide A were...
A library of analogues of the cyanobacterium-derived depsipeptide natural product gallinamide A were...
Falcipain-2 is a papain family cysteine protease and an emerging antimalarial drug target. A pseudo-...
PhD (Pharmaceutical Chemistry), North-West University, Potchefstroom Campus, 2014Malaria is endemic ...
Natural products, including peptides, offer a rich source of bioactive metabolites commonly exploite...
Malaria is currently endemic in 106 countries, with an estimated 216 million clinical cases and near...
We employed a comprehensive approach of target-based virtual high-throughput screening to find poten...
We employed a comprehensive approach of target-based virtual high-throughput screening to find poten...
AbstractThe cysteine protease, falcipain-2 is an important drug target in human malaria parasite Pla...
Thesis (PhD (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2013Malaria ha...
Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our curr...
Includes abstract.With the aim of designing appropriate hybrid molecules as a strategy to fight drug...
Falcipain-2 (FP-2) is a key cysteine protease from the malaria parasite Plasmodium falciparum. Many ...
Analogues of the natural product gallinamide A were prepared to elucidate novel inhibitors of the fa...
A library of analogues of the cyanobacterium-derived depsipeptide natural product gallinamide A were...
A library of analogues of the cyanobacterium-derived depsipeptide natural product gallinamide A were...
A library of analogues of the cyanobacterium-derived depsipeptide natural product gallinamide A were...
Falcipain-2 is a papain family cysteine protease and an emerging antimalarial drug target. A pseudo-...
PhD (Pharmaceutical Chemistry), North-West University, Potchefstroom Campus, 2014Malaria is endemic ...
Natural products, including peptides, offer a rich source of bioactive metabolites commonly exploite...
Malaria is currently endemic in 106 countries, with an estimated 216 million clinical cases and near...
We employed a comprehensive approach of target-based virtual high-throughput screening to find poten...
We employed a comprehensive approach of target-based virtual high-throughput screening to find poten...
AbstractThe cysteine protease, falcipain-2 is an important drug target in human malaria parasite Pla...
Thesis (PhD (Pharmaceutical Chemistry))--North-West University, Potchefstroom Campus, 2013Malaria ha...
Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our curr...
Includes abstract.With the aim of designing appropriate hybrid molecules as a strategy to fight drug...
Falcipain-2 (FP-2) is a key cysteine protease from the malaria parasite Plasmodium falciparum. Many ...